- About bilaterals.org
- Feb-2016: New ISDS platform launched
- Sep-2004: Launch announcement
- Feb-2015: Relaunch of bilaterals.org
- Mar-2013: Relaunch of bilaterals.org
- Jun-2009: Relaunch of bilaterals.org
- Dec-2008: An update from bilaterals.org and logo design contest announcement
- Dec-2006: bilaterals.org in Spanish & French
- Sep-2006: Update from bilaterals.org
- How to participate
- Key issues
- Texts of agreements
Millions will die if India stops AIDS drugs — UN
- A sex worker holds a placard during an AIDS awareness rally to mark the World AIDS Day in Siliguri December 1, 2008. REUTERS/Rupak De Chowdhuri/Files
Millions will die if India stops AIDS drugs — U.N.
By Nita Bhalla
NEW DELHI | Tue Jul 5, 2011
(Reuters) — Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday.
The EU and India are currently negotiating a free-trade agreement, which campaigners say will restrict India’s ability to produce anti-retroviral (ARV) drugs, preventing the world’s poor from accessing cheap drugs for their treatment.
"India should resist removing any flexibility because any trade agreement which could lead to India not being able to produce will be terrible for the rest of the world," said Michel Sidibe, executive director for the Joint United Nations Programme on HIV/AIDS (UNAIDS).
"Millions of people will die if India cannot produce and Africa will be the most affected. For me, it is an issue of life or death," he told Reuters in an interview, adding that about 86 percent of people on treatment were taking drugs made in India.
The EU-India trade deal includes measures that could delay or restrict competition from generic medicines by extending patent terms, requiring data exclusivity and tightening border enforcement rules.
Such moves could drive up prices for India’s anti-retroviral treatments, limit dosage options and delay access to newer and better drugs, said a U.N. report in September last year.
REVERSING GAINS MADE
Thirty years after the HIV/AIDS virus was first discovered, experts say while substantial progress has been made by the global community in stemming it, only a fraction of those living with the illness are on medication.
At a high level U.N. meeting last month, nations agreed on a set of ambitious targets to rid the world of disease, including scaling up the provision of generics to reach 15 million patients from six million by 2015.
The trade deal, Sidibe said, would reverse many of the gains made in improving the lives of the world’s poor.
"We have been fighting for so long to make sure that poor people could have access to treatment," he said. "For me, it will be the beginning of reversing all the gains we made on social justice and redistribution of opportunity."
Sidibe, a Mali national, said African leaders were asking India to really pay serious attention to any trade agreement which would block them to produce quality generic drugs for very poor people.
"It is not a rich pocket of people in the developed world who will be deprived of drugs, it will be the most needy, the most poor."
(Editing by Yoko Nishikawa)
News from the movements
7-Dec-2016 Radio UchileA la audiencia ante la CIDH asiste una delegación con representantes indígenas y de sociedad civil que forman parte de las entidades peticionarias de los tres países, además del Grupo Internacional de Trabajo sobre Asuntos Indígenas.
7-Dec-2016 Coalition Nationale Non aux APEOui à une intégration africaine souveraine et populaire
5-Dec-2016 Médecins Sans Frontières
MSF press release: RCEP trade deal negotiators must reject terms that would harm access to medicinesInternational medical humanitarian organisation Médecins Sans Frontières (MSF), along with other health groups, reiterated concerns about harmful intellectual property provisions in the proposed agreement that would increase market monopolies for pharmaceutical corporations and delay or block access to affordable generic medicines.
30-Nov-2016 No al TTIPCientos de organizaciones europeas y canadienses instan a las/los legisladores a votar en contra del Acuerdo Integral de Economía y Comercio (CETA).
30-Nov-2016 Temp.coJelang perundingan perdagangan bebas ASEAN RCEP (Regional Comprehensive Economic Partnership) di Indonesia, organisasi masyarakat sipil dari berbagai negara mulai melayangkan protes kepada pemerintah di negara-negara yang akan menandatangani perjanjian tersebut.
30-Nov-2016Este es un llamamiento urgente de 316 organizaciones de la sociedad civil de los países de Asia y el Pacífico que negocian la Asociación Económica Regional Ampliada para que el contenido tóxico del TPPT no se incorpore al RCEP
29-Nov-2016This is an urgent call by 316 civil society organisations from across the Asian and Pacific countries negotiating the Regional Comprehensive Economic Partnership to reject TPP rules in the RCEP
29-Nov-2016 S2BWe, the undersigned civil society organisations from Canada and Europe, hereby express our deep concern about the Comprehensive Economic and Trade Agreement (CETA) between the EU and Canada.
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Get involved.